Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Fischereder

Showing results (111-120 of 111) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 111 results.
Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpuraLinus A Völker, Jessica Kaufeld, Gesa Balduin, et al.
Pageof 12

Showing results (111-120 of 111) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 111 results.
Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpuraLinus A Völker, Jessica Kaufeld, Gesa Balduin, et al.
Pageof 12